| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue from contract with customer, excluding assessed tax | - | - | - | 132 |
| Cost of revenue | 31 | 342 | 253 | 414 |
| Research and development | 2,774 | 1,971 | 3,659 | 1,217 |
| Selling, general, and administrative | 2,916 | 2,404 | 3,485 | 2,926 |
| Total cost of revenue and operating expenses | 5,721 | 4,717 | 7,397 | 4,557 |
| Loss from operations | -5,721 | -4,717 | -7,397 | -4,425 |
| Convertible notes fair value adjustment | 3,508 | -1,427 | -190 | -3,255 |
| Warrant liabilities fair value adjustment | 231 | 141 | -38 | -4,973 |
| Interest expense | 749 | 720 | 662 | 435 |
| Interest income | 79 | 102 | 164 | 166 |
| Other (expense) income, net | 12 | 102 | -46 | 72 |
| Total other (loss) income, net | -4,397 | 770 | -316 | 8,031 |
| Net (loss) income | -10,118 | -3,947 | -7,713 | 3,606 |
| Foreign currency translation adjustment | 4 | -39 | -61 | -9 |
| Comprehensive (loss) income | -10,114 | -3,986 | -7,774 | 3,597 |
| Earnings per share, basic | -0.66 | -0.26 | -0.5 | 0.18 |
| Earnings per share, diluted | -0.66 | -0.35 | -0.51 | 0.02 |
| Weighted average number of shares outstanding, basic | 15,381,565 | 15,381,565 | 15,375,521 | 14,057,636 |
| Weighted average number of shares outstanding, diluted | 15,381,565 | 15,381,565 | 15,375,521 | 16,057,636 |
Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. (ADGM)